The good old days of producing an effective product and winning market share by securing physician alliances are long gone. Pharma manufacturers now face pressure from all sides.

Consumers clamor for better and less expensive medications; to save money, some buy drugs online while others organize bus trips to Canada. Patients, flush with information gleaned from the Internet, are more actively involved in therapy choices than ever. Regulatory agencies, most notably in the US, scrutinize a drug maker’s every move, monitoring not just the safety and efficacy of a new drug but also the “need”. The emergence of managed care has changed everything. Twenty years ago, the success of an ethical (prescription-only) product relied on the detail effort; now, it is equally important to be “on formulary”.

With such a complex category, and with so much riding on a particular drug’s success, our clients rely heavily on fast, accurate, insightful research to help them navigate wisely.

To learn more about MSI's point of view,
just click on any question above.